Skip to content

Chad E Groer

3 papers in the library · 115 citations · publishing 2008-2014

Papers

Sort Most recent Most cited

Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.

Journal of Medicinal Chemistry December 26, 2014 Andrew P Riley, Chad E Groer, David Young et al. 115 citations

The neoclerodane diterpene salvinorin A, found in the leaves of Salvia divinorum, is a potent κ-opioid receptor agonist, making it an attractive scaffold for development into a treatment for substance abuse. Although several successful semisynthetic studies have been performed to elucidate structure-activity relationships, the lack of analogues with substitutions to the furan ring of salvinorin...

Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues.

Bioorganic & Medicinal Chemistry Letters January 15, 2012 Cécile Béguin, Justin Potuzak, Wei Xu et al.

The kappa opioid receptor (KOPR) has been identified as a potential drug target to prevent or alter the course of mood, anxiety and addictive disorders or reduce response to stress. In a search for highly potent and selective KOPR partial agonists as pharmacological tools, we have modified 12-epi-salvinorin A, a compound which we have previously observed to be a KOPR partial agonist. Five...

Herkinorin analogues with differential beta-arrestin-2 interactions.

Journal of Medicinal Chemistry April 24, 2008 Kevin Tidgewell, Chad E Groer, Wayne W Harding et al.

Salvinorin A is a psychoactive natural product that has been found to be a potent and selective kappa opioid receptor agonist in vitro and in vivo. The activity of salvinorin A is unusual compared to other opioids such as morphine in that it mediates potent kappa opioid receptor signaling yet leads to less receptor downregulation than observed with other kappa agonists. Our initial chemical...